The costs of treating hypertension

Cardiovascular Drugs and Therapy
M Moser

Abstract

Recent surveys in the U.S. have reported, for the first time, that a significant number of patients with hypertension are finding that the cost of medication and treatment in general is an obstacle to treatment. The cost of management of hypertension can be contained if: a) the diagnostic workup is kept simple (this does not include the use of routine echocardiography or 24-hour monitoring) and b) medications that are relatively inexpensive and easily titratable on one or two visits are chosen. Despite some claims to the contrary, there are relatively few instances where significant metabolic changes are noted, regardless of the medication chosen, that require repeated blood determinations or frequent office visits.

References

Jul 1, 1976·The American Journal of Cardiology·W B KannelT Gordon
Jan 17, 1977·JAMA : the Journal of the American Medical Association·W R Barclay
Oct 1, 1986·Hypertension·R M Zusman
Dec 31, 1986·The American Journal of Medicine·G Gallup, H E Cotugno
Sep 1, 1988·Hypertension·M Moser
Sep 1, 1986·American Journal of Public Health·N B ShulmanC G Miles
Dec 31, 1986·The American Journal of Medicine·W B Stason
Oct 1, 1985·Journal of Hypertension·M Moser, R W Gifford
Jun 1, 1981·American Heart Journal·N M Kaplan
May 27, 1983·JAMA : the Journal of the American Medical Association·D PerloffR Cowan

❮ Previous
Next ❯

Citations

Sep 1, 1990·The American Journal of the Medical Sciences·W G Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.